Loss of cortical acetylcholine enhances amphetamine-induced locomotor activity

Neuroscience

Volumn 127, Issue 3, 2004, Pages 579-591

  Mattsson, A ^a   Pernold, K ^a   Ogren S O ^a   Olson, L ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

acetylcholine; acetylcholine esterase; ACh; AChE; hippocampus; i.c.v.; intracerebroventricular; medial septum vertical diagonal band; MS vDB; NBM; nucleus basalis; nucleus basalis magnocellularis; PBS; phosphate buffered saline; saporin; schizophrenia; septum

Indexed keywords

ACETYLCHOLINE; AMPHETAMINE; IMMUNOGLOBULIN G; SAPORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; CELL LOSS; CEREBELLUM; CHOLINERGIC ACTIVITY; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DENERVATION; DIAGONAL BAND OF BROCA; DOPAMINERGIC ACTIVITY; FEMALE; HIPPOCAMPUS; LOCOMOTION; MAGNOCELLULAR NUCLEUS; MELANOSIS; NONHUMAN; OLIVARY NUCLEUS; PARENCHYMA; PRIORITY JOURNAL; PURKINJE CELL; RAT; SCHIZOPHRENIA;

ACETYLCHOLINE; AMPHETAMINE; ANIMALS; ANTIBODIES, MONOCLONAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL CORTEX; CHOLINERGIC AGENTS; CHOLINERGIC FIBERS; DENERVATION; FEMALE; HIPPOCAMPUS; IMMUNOTOXINS; INJECTIONS, INTRAVENTRICULAR; MOTOR ACTIVITY; N-GLYCOSYL HYDROLASES; NEURAL PATHWAYS; PURKINJE CELLS; RATS; RATS, SPRAGUE-DAWLEY; SEPTUM OF BRAIN;

EID: 3343008626     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.05.038     Document Type: Article

References (61)

1. Abi-Dargham A., Gil R., Krystal J., Baldwin R.M., Seibyl J.P., Bowers M., van Dyck C.H., Charney D.S., Innis R.B., Laruelle M. Increased striatal dopamine transmission in schizophrenia Confirmation in a second cohort. Am J Psychiatry. 155:1998;761-767
2. Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., Flach K., Nagamoto H., Bickford P., Leonard S., Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull. 24:1998;189-202
3. Adler L.E., Waldo M.C., Freedman R. Neurophysiologic studies of sensory gating in schizophrenia Comparison of auditory and visual responses. Biol Psychiatry. 20:1985;1284-1296
4. Angner R.T., Kelly R.M., Wiley R.G., Walsh T.J., Reuhl K.R. Preferential destruction of cerebellar Purkinje cells by OX7-saporin. Neurotoxicology. 21:2000;395-403
5. Angrist B.M., Gershon S. The phenomenology of experimentally induced amphetamine psychosis-preliminary observations. Biol Psychiatry. 2:1970;95-107
6. Ballmaier M., Casamenti F., Zoli M., Pepeu G., Spano P. Selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis impairs prepulse inhibition of acoustic startle. Neuroscience. 108:2001;299-305
7. Balse E., Suhr R., Haaf A., Kelche C., Jackisch R., Cassel J.C. The potentiation of amphetamine-induced hyperlocomotion by fimbria- fornix lesions in rats is abolished by intrahippocampal grafts rich in serotonergic neurons. Neurosci Lett. 265:1999;79-82
8. Bigl V., Woolf N.J., Butcher L.L. Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices A combined fluorescent tracer and acetylcholinesterase analysis. Brain Res Bull. 8:1982;727-749
9. Birthelmer A., Lazaris A., Riegert C., Marques Pereira P., Koenig J., Jeltsch H., Jackisch R., Cassel J.C. Does the release of acetylcholine in septal slices originate from intrinsic cholinergic neurons bearing p75(NTR) receptors? A study using 192 IgG-saporin lesions in rats. Neuroscience. 122:2003;1059-1071
10. Breier A. Cognitive deficit in schizophrenia and its neurochemical basis. Br J Psychiatry Suppl. 37:1999;16-18
11. Breier A., Su T.P., Saunders R., Carson R.E., Kolachana B.S., de Bartolomeis A., Weinberger D.R., Weisenfeld N., Malhotra A.K., Eckelman W.C., Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations Evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA. 94:1997;2569-2574
12. Bymaster F.P., Shannon H.E., Rasmussen K., DeLapp N.W., Ward J.S., Calligaro D.O., Mitch C.H., Whitesitt C., Ludvigsen T.S., Sheardown M., Swedberg M., Rasmussen T., Olesen P.H., Jeppesen L., Sauerberg P., Fink-Jensen A. Potential role of muscarinic receptors in schizophrenia. Life Sci. 64:1999;527-534
13. Cassel J.C., Cassel S., Galani R., Kelche C., Will B., Jarrard L. Fimbria-fornix vs selective hippocampal lesions in rats Effects on locomotor activity and spatial learning and memory. Neurobiol Learn Mem. 69:1998;22-45
14. Court J., Spurden D., Lloyd S., McKeith I., Ballard C., Cairns N., Kerwin R., Perry R., Perry E. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia Alpha-bungarotoxin and nicotine binding in the thalamus. J Neurochem. 73:1999;1590-1597
15. Coutureau E., Galani R., Jarrard L.E., Cassel J.C. Selective lesions of the entorhinal cortex, the hippocampus, or the fimbria-fornix in rats A comparison of effects on spontaneous and amphetamine-induced locomotion. Exp Brain Res. 131:2000;381-392
16. Crook J.M., Tomaskovic-Crook E., Copolov D.L., Dean B. Decreased muscarinic receptor binding in subjects with schizophrenia A study of the human hippocampal formation. Biol Psychiatry. 48:2000;381-388
17. Crook J.M., Tomaskovic-Crook E., Copolov D.L., Dean B. Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia A study of brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment. Am J Psychiatry. 158:2001;918-925
18. Davis T.L., Wiley R.G. Anti-Thy-1 immunotoxin, OX7-saporin, destroys cerebellar Purkinje cells after intraventricular injection in rats. Brain Res. 504:1989;216-222
19. Dean B., Crook J.M., Opeskin K., Hill C., Keks N., Copolov D.L. The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia. Mol Psychiatry. 1:1996;54-58
20. Everitt B.J., Robbins T.W. Central cholinergic systems and cognition. Annu Rev Psychol. 48:1997;649-684
21. Felder C.C., Porter A.C., Skillman T.L., Zhang L., Bymaster F.P., Nathanson N.M., Hamilton S.E., Gomeza J., Wess J., McKinzie D.L. Elucidating the role of muscarinic receptors in psychosis. Life Sci. 68:2001;2605-2613
22. Ferencz I., Leanza G., Nanobashvili A., Kokaia M., Lindvall O. Basal forebrain neurons suppress amygdala kindling via cortical but not hippocampal cholinergic projections in rats. Eur J Neurosci. 12:2000;2107-2116
23. Freedman R., Adams C.E., Leonard S. The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia. J Chem Neuroanat. 20:2000;299-306
24. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA. 94:1997;587-592
25. Freedman R., Hall M., Adler L.E., Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry. 38:1995;22-33
26. Gandhi C.C., Kelly R.M., Wiley R.G., Walsh T.J. Impaired acquisition of a Morris water maze task following selective destruction of cerebellar purkinje cells with OX7-saporin. Behav Brain Res. 109:2000;37-47
27. Gerber D.J., Sotnikova T.D., Gainetdinov R.R., Huang S.Y., Caron M.G., Tonegawa S. Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci USA. 98:2001;15312-15317
28. Gibbs R.B. Fluctuations in relative levels of choline acetyltransferase mRNA in different regions of the rat basal forebrain across the estrous cycle Effects of estrogen and progesterone. J Neurosci. 16:1996;1049-1055
29. Guan Z.Z., Zhang X., Blennow K., Nordberg A. Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport. 10:1999;1779-1782
30. Harvey P.D., Howanitz E., Parrella M., White L., Davidson M., Mohs R.C., Hoblyn J., Davis K.L. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia A comparison across treatment sites. Am J Psychiatry. 155:1998;1080-1086
31. Heckers S., Ohtake T., Wiley R.G., Lappi D.A., Geula C., Mesulam M.M. Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. J Neurosci. 14:1994;1271-1289
32. Heimer L. Basal forebrain in the context of schizophrenia. Brain Res Brain Res Rev. 31:2000;205-235
33. Hooks M.S., Jones G.H., Smith A.D., Neill D.B., Justice J.B. Jr. Individual differences in locomotor activity and sensitization. Pharmacol Biochem Behav. 38:1991;467-470
34. Ichikawa J., Chung Y.C., Li Z., Dai J., Meltzer H.Y. Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Brain Res. 958:2002;176-184
35. Ichikawa J., Dai J., O'Laughlin I.A., Fowler W.L., Meltzer H.Y. Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology. 26:2002;325-339
36. Karnovsky MJ, Roots L (1964) A "direct-coloring" thiocholine method for cholinesterase. J Histochem Cytochem 219-221.
37. Laruelle M., Abi-Dargham A., van Dyck C.H., Gil R., D'Souza C.D., Erdos J., McCance E., Rosenblatt W., Fingado C., Zoghbi S.S., Baldwin R.M., Seibyl J.P., Krystal J.H., Charney D.S., Innis R.B. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA. 93:1996;9235-9240
38. Leonard S., Adams C., Breese C.R., Adler L.E., Bickford P., Byerley W., Coon H., Griffith J.M., Miller C., Myles-Worsley M., Nagamoto H.T., Rollins Y., Stevens K.E., Waldo M., Freedman R. Nicotinic receptor function in schizophrenia. Schizophr Bull. 22:1996;431-445
39. Lieberman J.A., Kane J.M., Alvir J. Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology (Berl). 91:1987;415-433
40. Lipska B.K., Jaskiw G.E., Chrapusta S., Karoum F., Weinberger D.R. Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat. Brain Res. 585:1992;1-6
41. Mattsson A., Ögren S.O., Olson L. Facilitation of dopamine-mediated locomotor activity in adult rats following cholinergic denervation. Exp Neurol. 174:2002;96-108
42. McGaughy J., Dalley J.W., Morrison C.H., Everitt B.J., Robbins T.W. Selective behavioral and neurochemical effects of cholinergic lesions produced by intrabasalis infusions of 192 IgG-saporin on attentional performance in a five-choice serial reaction time task. J Neurosci. 22:2002;1905-1913
43. Meltzer H.Y., McGurk S.R. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull. 25:1999;233-255
44. Meltzer H.Y., Sumiyoshi T. Atypical antipsychotic drugs improve cognition in schizophrenia. Biol Psychiatry. 53:2003;265-267
45. Mittleman G., Bratt A.M., Chase R. Heterogeneity of the hippocampus Effects of subfield lesions on locomotion elicited by dopaminergic agonists. Behav Brain Res. 92:1998;31-45
46. Muir J.L., Everitt B.J., Robbins T.W. AMPA-induced excitotoxic lesions of the basal forebrain A significant role for the cortical cholinergic system in attentional function. J Neurosci. 14:1994;2313-2326
47. Ögren S.O., Hall H., Kohler C., Magnusson O., Sjostrand S.E. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions. Psychopharmacology (Berl). 90:1986;287-294
48. Perry E., Walker M., Grace J., Perry R. Acetylcholine in mind A neurotransmitter correlate of consciousness? Trends Neurosci. 22:1999;273-280
49. Purdon S.E. Cognitive improvement in schizophrenia with novel antipsychotic medications. Schizophr Res. 35:(Suppl):1999;S51-S60
50. Raedler T.J., Knable M.B., Jones D.W., Urbina R.A., Gorey J.G., Lee K.S., Egan M.F., Coppola R., Weinberger D.R. In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia. Am J Psychiatry. 160:2003;118-127
51. Sarter M., Bruno J.P. Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders. Trends Neurosci. 22:1999;67-74
52. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse. 1:1987;133-152
53. Shannon H.E., Rasmussen K., Bymaster F.P., Hart J.C., Peters S.C., Swedberg M.D., Jeppesen L., Sheardown M.J., Sauerberg P., Fink-Jensen A. Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice. Schizophr Res. 42:2000;249-259
54. Steriade M., Parent A., Pare D., Smith Y. Cholinergic and non-cholinergic neurons of cat basal forebrain project to reticular and mediodorsal thalamic nuclei. Brain Res. 408:1987;372-376
55. Thompson T.L., Moss R.L. Modulation of mesolimbic dopaminergic activity over the rat estrous cycle. Neurosci Lett. 229:1997;145-148
56. Waite J.J., Chen A.D. Differential changes in rat cholinergic parameters subsequent to immunotoxic lesion of the basal forebrain nuclei. Brain Res. 918:2001;113-120
57. Waite J.J., Wardlow M.L., Power A.E. Deficit in selective and divided attention associated with cholinergic basal forebrain immunotoxic lesion produced by 192-saporin; motoric/sensory deficit associated with Purkinje cell immunotoxic lesion produced by OX7-saporin. Neurobiol Learn Mem. 71:1999;325-352
58. Whishaw I.Q., Mittleman G. Hippocampal modulation of nucleus accumbens Behavioral evidence from amphetamine-induced activity profiles. Behav Neural Biol. 55:1991;289-306
59. Wiley R.G., Oeltmann T.N., Lappi D.A. Immunolesioning Selective destruction of neurons using immunotoxin to rat NGF receptor. Brain Res. 562:1991;149-153
60. Wilkinson L.S., Mittleman G., Torres E., Humby T., Hall F.S., Robbins T.W. Enhancement of amphetamine-induced locomotor activity and dopamine release in nucleus accumbens following excitotoxic lesions of the hippocampus. Behav Brain Res. 55:1993;143-150
61. Wrenn C.C., Wiley R.G. Lack of effect of moderate Purkinje cell loss on working memory. Neuroscience. 107:2001;433-445